vs
Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and LEAR CORP (LEA). Click either name above to swap in a different company.
LEAR CORP is the larger business by last-quarter revenue ($6.0B vs $5.5B, roughly 1.1× Fresenius Medical Care AG). Fresenius Medical Care AG runs the higher net margin — 7.9% vs 1.4%, a 6.5% gap on every dollar of revenue. On growth, LEAR CORP posted the faster year-over-year revenue change (4.8% vs -0.3%).
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
Lear Corporation is an American company that manufactures automotive seating and electrical systems. In 2019, it ranked #147 and in 2018, it ranked #148 on the Fortune 500 list.
FMS vs LEA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.5B | $6.0B |
| Net Profit | $434.2M | $82.7M |
| Gross Margin | 27.4% | 5.7% |
| Operating Margin | 11.7% | 2.6% |
| Net Margin | 7.9% | 1.4% |
| Revenue YoY | -0.3% | 4.8% |
| Net Profit YoY | 240.4% | -6.1% |
| EPS (diluted) | — | $1.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.5B | $6.0B | ||
| Q3 25 | — | $5.7B | ||
| Q2 25 | — | $6.0B | ||
| Q1 25 | — | $5.6B | ||
| Q4 24 | $5.5B | $5.7B | ||
| Q3 24 | — | $5.6B | ||
| Q2 24 | — | $6.0B | ||
| Q1 24 | — | $6.0B |
| Q4 25 | $434.2M | $82.7M | ||
| Q3 25 | — | $108.2M | ||
| Q2 25 | — | $165.2M | ||
| Q1 25 | — | $80.7M | ||
| Q4 24 | $127.6M | $88.1M | ||
| Q3 24 | — | $135.8M | ||
| Q2 24 | — | $173.1M | ||
| Q1 24 | — | $109.6M |
| Q4 25 | 27.4% | 5.7% | ||
| Q3 25 | — | 6.4% | ||
| Q2 25 | — | 7.3% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | 25.0% | 6.8% | ||
| Q3 24 | — | 7.3% | ||
| Q2 24 | — | 7.5% | ||
| Q1 24 | — | 6.6% |
| Q4 25 | 11.7% | 2.6% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 4.1% | ||
| Q1 25 | — | 3.3% | ||
| Q4 24 | 5.1% | 3.7% | ||
| Q3 24 | — | 3.9% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | — | 3.3% |
| Q4 25 | 7.9% | 1.4% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 2.7% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | 2.3% | 1.5% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 2.9% | ||
| Q1 24 | — | 1.8% |
| Q4 25 | — | $1.58 | ||
| Q3 25 | — | $2.02 | ||
| Q2 25 | — | $3.06 | ||
| Q1 25 | — | $1.49 | ||
| Q4 24 | — | $1.64 | ||
| Q3 24 | — | $2.41 | ||
| Q2 24 | — | $3.02 | ||
| Q1 24 | — | $1.90 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $1.0B |
| Total DebtLower is stronger | — | $2.7B |
| Stockholders' EquityBook value | $15.4B | $5.0B |
| Total Assets | $33.5B | $14.8B |
| Debt / EquityLower = less leverage | — | 0.54× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $1.0B | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | — | $887.9M | ||
| Q1 25 | — | $779.9M | ||
| Q4 24 | $1.3B | $1.1B | ||
| Q3 24 | — | $763.9M | ||
| Q2 24 | — | $950.3M | ||
| Q1 24 | — | $930.4M |
| Q4 25 | — | $2.7B | ||
| Q3 25 | — | $2.8B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | — | $2.7B | ||
| Q1 24 | — | $2.7B |
| Q4 25 | $15.4B | $5.0B | ||
| Q3 25 | — | $5.1B | ||
| Q2 25 | — | $5.1B | ||
| Q1 25 | — | $4.7B | ||
| Q4 24 | $17.0B | $4.5B | ||
| Q3 24 | — | $4.8B | ||
| Q2 24 | — | $4.8B | ||
| Q1 24 | — | $4.9B |
| Q4 25 | $33.5B | $14.8B | ||
| Q3 25 | — | $15.2B | ||
| Q2 25 | — | $15.3B | ||
| Q1 25 | — | $14.6B | ||
| Q4 24 | $36.3B | $14.0B | ||
| Q3 24 | — | $14.8B | ||
| Q2 24 | — | $14.7B | ||
| Q1 24 | — | $14.9B |
| Q4 25 | — | 0.54× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.54× | ||
| Q1 25 | — | 0.59× | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 0.58× | ||
| Q2 24 | — | 0.57× | ||
| Q1 24 | — | 0.56× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.9B | $475.9M |
| Free Cash FlowOCF − Capex | — | $281.1M |
| FCF MarginFCF / Revenue | — | 4.7% |
| Capex IntensityCapex / Revenue | — | 3.3% |
| Cash ConversionOCF / Net Profit | 6.67× | 5.75× |
| TTM Free Cash FlowTrailing 4 quarters | — | $527.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9B | $475.9M | ||
| Q3 25 | — | $444.4M | ||
| Q2 25 | — | $296.2M | ||
| Q1 25 | — | $-127.7M | ||
| Q4 24 | $2.6B | $680.8M | ||
| Q3 24 | — | $182.7M | ||
| Q2 24 | — | $291.2M | ||
| Q1 24 | — | $-34.6M |
| Q4 25 | — | $281.1M | ||
| Q3 25 | — | $307.0M | ||
| Q2 25 | — | $170.8M | ||
| Q1 25 | — | $-231.7M | ||
| Q4 24 | — | $488.7M | ||
| Q3 24 | — | $50.5M | ||
| Q2 24 | — | $170.4M | ||
| Q1 24 | — | $-148.2M |
| Q4 25 | — | 4.7% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | -4.2% | ||
| Q4 24 | — | 8.6% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | -2.5% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | — | 2.4% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 1.9% |
| Q4 25 | 6.67× | 5.75× | ||
| Q3 25 | — | 4.11× | ||
| Q2 25 | — | 1.79× | ||
| Q1 25 | — | -1.58× | ||
| Q4 24 | 20.20× | 7.73× | ||
| Q3 24 | — | 1.35× | ||
| Q2 24 | — | 1.68× | ||
| Q1 24 | — | -0.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FMS
Segment breakdown not available.
LEA
| Other | $3.5B | 59% |
| Seating Segment | $1.9B | 32% |
| E Systems Segment | $520.6M | 9% |
